163 related articles for article (PubMed ID: 35743773)
1. TRIM24 Expression as an Independent Biomarker for Prognosis and Tumor Recurrence in HNSCC.
Klapper L; Idel C; Kuppler P; Jagomast T; von Bernuth A; Bruchhage KL; Rades D; Offermann A; Kirfel J; Perner S; Ribbat-Idel J
J Pers Med; 2022 Jun; 12(6):. PubMed ID: 35743773
[TBL] [Abstract][Full Text] [Related]
2. TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes.
Cui Z; Cao W; Li J; Song X; Mao L; Chen W
PLoS One; 2013; 8(5):e63887. PubMed ID: 23717505
[TBL] [Abstract][Full Text] [Related]
3. NR2F6 as a Prognostic Biomarker in HNSCC.
Klapper L; Ribbat-Idel J; Kuppler P; Paulsen FO; Bruchhage KL; Rades D; Offermann A; Kirfel J; Wollenberg B; Idel C; Perner S
Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32752295
[TBL] [Abstract][Full Text] [Related]
4. TRIM24 as an independent prognostic biomarker for prostate cancer.
Offermann A; Roth D; Hupe MC; Hohensteiner S; Becker F; Joerg V; Carlsson J; Kuempers C; Ribbat-Idel J; Tharun L; Sailer V; Kirfel J; Svensson M; Andren O; Lubczyk V; Kuefer R; Merseburger AS; Perner S
Urol Oncol; 2019 Sep; 37(9):576.e1-576.e10. PubMed ID: 31178279
[TBL] [Abstract][Full Text] [Related]
5. Glucose transporter 4 promotes head and neck squamous cell carcinoma metastasis through the TRIM24-DDX58 axis.
Chang YC; Chi LH; Chang WM; Su CY; Lin YF; Chen CL; Chen MH; Chang PM; Wu AT; Hsiao M
J Hematol Oncol; 2017 Jan; 10(1):11. PubMed ID: 28061796
[TBL] [Abstract][Full Text] [Related]
6. TSPO is a potential independent prognostic factor associated with cellular respiration and p16 in head and neck squamous cell carcinoma.
Tuominen S; Nissi L; Kukkula A; Routila J; Huusko T; Leivo I; Minn H; Irjala H; Löyttyniemi E; Ventelä S; Sundvall M; Grönroos TJ
Front Oncol; 2023; 13():1298333. PubMed ID: 38162485
[TBL] [Abstract][Full Text] [Related]
7. Elevated LSD1 and SNAIL Expression Indicate Poor Prognosis in Hypopharynx Carcinoma.
Bottner J; Ribbat-Idel J; Klapper L; Jagomast T; Lemster AL; Perner S; Idel C; Kirfel J
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563463
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of TRIM24 Stimulates Proliferation and Glucose Metabolism of Head and Neck Squamous Cell Carcinoma.
Wang H; Xue W; Jiang X
Biomed Res Int; 2018; 2018():6142843. PubMed ID: 29862279
[TBL] [Abstract][Full Text] [Related]
9. MAGE-A11 Expression Predicts Patient Prognosis in Head and Neck Squamous Cell Carcinoma.
Jia S; Zhang M; Li Y; Zhang L; Dai W
Cancer Manag Res; 2020; 12():1427-1435. PubMed ID: 32161495
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of tripartite motif containing 24 expression in colorectal cancer.
Wang FQ; Han Y; Yao W; Yu J
Pathol Res Pract; 2017 Oct; 213(10):1271-1275. PubMed ID: 28916426
[TBL] [Abstract][Full Text] [Related]
11. CDK7 Predicts Worse Outcome in Head and Neck Squamous-Cell Cancer.
Jagomast T; Idel C; Klapper L; Kuppler P; Offermann A; Dreyer E; Bruchhage KL; Ribbat-Idel J; Perner S
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158760
[TBL] [Abstract][Full Text] [Related]
12. Cyclin A as a predictive factor for chemotherapy response in advanced head and neck cancer.
Rodriguez-Pinilla M; Rodriguez-Peralto JL; Hitt R; Sanchez JJ; Ballestin C; Diez A; Sanchez-Verde L; Alameda F; Sanchez-Cespedes M
Clin Cancer Res; 2004 Dec; 10(24):8486-92. PubMed ID: 15623629
[TBL] [Abstract][Full Text] [Related]
13. Expression of PD-1/PD-L1 in head and neck squamous cell carcinoma and its clinical significance.
Chen SW; Li SH; Shi DB; Jiang WM; Song M; Yang AK; Li YD; Bei JX; Chen WK; Zhang Q
Int J Biol Markers; 2019 Dec; 34(4):398-405. PubMed ID: 31674884
[TBL] [Abstract][Full Text] [Related]
14. An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.
Citron F; Armenia J; Franchin G; Polesel J; Talamini R; D'Andrea S; Sulfaro S; Croce CM; Klement W; Otasek D; Pastrello C; Tokar T; Jurisica I; French D; Bomben R; Vaccher E; Serraino D; Belletti B; Vecchione A; Barzan L; Baldassarre G
Clin Cancer Res; 2017 Jul; 23(14):3769-3780. PubMed ID: 28174235
[No Abstract] [Full Text] [Related]
15. The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas.
Zhang Z; Yang XF; Huang KQ; Ren L; Gou WF; Shen DF; Zhao S; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2015 Dec; 36(12):9487-97. PubMed ID: 26124004
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma.
Yao Y; Yan Z; Lian S; Wei L; Zhou C; Feng D; Zhang Y; Yang J; Li M; Chen Y
J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32719094
[TBL] [Abstract][Full Text] [Related]
17. Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.
Szentkúti G; Dános K; Brauswetter D; Kiszner G; Krenács T; Csákó L; Répássy G; Tamás L
Pathol Oncol Res; 2015 Jul; 21(3):643-50. PubMed ID: 25547827
[TBL] [Abstract][Full Text] [Related]
18. CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC.
Paulsen FO; Idel C; Ribbat-Idel J; Kuppler P; Klapper L; Rades D; Bruchhage KL; Wollenberg B; Brägelmann J; Perner S; Offermann A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752128
[TBL] [Abstract][Full Text] [Related]
19. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
Zhang L; Chen H; Ding B; Jiang W
J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
[TBL] [Abstract][Full Text] [Related]
20. Langerhans cell number is a strong and independent prognostic factor for head and neck squamous cell carcinomas.
Kindt N; Descamps G; Seminerio I; Bellier J; Lechien JR; Pottier C; Larsimont D; Journé F; Delvenne P; Saussez S
Oral Oncol; 2016 Nov; 62():1-10. PubMed ID: 27865360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
